Zomedica Statistics
Want to see ZOMDF full AI Analyst Report?
Zomedica (ZOMDF) Stock Statistics & Valuation Metrics
Total Valuation
Zomedica has a market cap or net worth of $95.10M. The enterprise value is $39.92M.
- Market Cap
- $95.10M
- Enterprise Value
- $39.92M
Share Statistics
Zomedica has 979,949,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 979,949,650
- Owned by Insiders
- 2.76%
- Owned by Institutions
- 0.01%
Financial Efficiency
Zomedica’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -12.41%.
- Return on Equity (ROE)
- -0.14
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -12.41%
- Return on Capital Employed (ROCE)
- -0.13
- Revenue Per Employee
- 174.90K
- Profits Per Employee
- -239.78K
- Employee Count
- 144
- Asset Turnover
- 0.10
- Inventory Turnover
- 1.54
Valuation Ratios
The current PE Ratio of Zomedica is -1.53. Zomedica’s PEG ratio is 0.14.
- PE Ratio
- -1.53
- PS Ratio
- 3.57
- PB Ratio
- 0.47
- Price to FCF
- -4.85
- Price to Operating Cash Flow
- -4.00
- PEG Ratio
- 0.14
Income Statement
In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.
- Revenue
- 25.19M
- Gross Profit
- 17.32M
- Operating Income
- -31.59M
- Pretax Income
- -35.86M
- Net Income
- -34.53M
- EBITDA
- -29.39M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -23.83M and capital expenditures 4.19M, giving a free cash flow of -19.64M billion.
- Operating Cash Flow
- -23.83M
- Free Cash Flow
- -19.64M
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Zomedica pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.60%
- Earnings Yield
- -65.23%
Stock Price Statistics
- Beta
- 0.11
- 52-Week Price Change
- 5.32%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.10
- Relative Strength Index (RSI)
- 75.38
- Average Volume (3m)
- 871.02K
Important Dates
Zomedica upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Zomedica as a current ratio of 11.06, with Debt / Equity ratio of 1.14%
- Current Ratio
- 11.06
- Quick Ratio
- 10.49
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.35
- Interest Coverage Ratio
- -180.53
Taxes
In the past 12 months, Zomedica has paid -1.33M in taxes.
- Income Tax
- -1.33M
- Effective Tax Rate
- 0.04
Enterprise Valuation
Zomedica EV to EBITDA ratio is -1.62, with an EV/FCF ratio of -4.46.
- EV to Sales
- 3.28
- EV to EBITDA
- -1.62
- EV to Free Cash Flow
- -4.46
- EV to Operating Cash Flow
- -3.68
Balance Sheet
Zomedica has $76.88M in cash and marketable securities with $2.08M in debt, giving a net cash position of $74.80M billion.
- Cash & Marketable Securities
- $76.88M
- Total Debt
- $2.08M
- Net Cash
- $74.80M
- Net Cash Per Share
- $0.08
- Tangible Book Value Per Share
- $0.11
Margins
Gross margin is 55.24%, with operating margin of -143.14%, and net profit margin of -232.70%.
- Gross Margin
- 55.24%
- Operating Margin
- -143.14%
- Pretax Margin
- -232.24%
- Net Profit Margin
- -232.70%
- EBITDA Margin
- -203.03%
- EBIT Margin
- -232.24%
Analyst Forecast
The average price target for Zomedica is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 31.33%
- EPS Growth Forecast
- 81.09%
Scores
- Smart Score
- 5
- AI Score
- 47.3
